Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,953 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Expression genomics of cervical cancer: molecular classification and prediction of radiotherapy response by DNA microarray.
Wong YF, Selvanayagam ZE, Wei N, Porter J, Vittal R, Hu R, Lin Y, Liao J, Shih JW, Cheung TH, Lo KW, Yim SF, Yip SK, Ngong DT, Siu N, Chan LK, Chan CS, Kong T, Kutlina E, McKinnon RD, Denhardt DT, Chin KV, Chung TK. Wong YF, et al. Among authors: porter j. Clin Cancer Res. 2003 Nov 15;9(15):5486-92. Clin Cancer Res. 2003. PMID: 14654527
Tissue inhibitor of metalloproteinases-1 stimulates gene expression in MDA-MB-435 human breast cancer cells by means of its ability to inhibit metalloproteinases.
Porter JF, Sharma S, Wilson DL, Kappil MA, Hart RP, Denhardt DT. Porter JF, et al. Breast Cancer Res Treat. 2005 Nov;94(2):185-93. doi: 10.1007/s10549-005-7728-4. Breast Cancer Res Treat. 2005. PMID: 16142437
This stimulation has been shown to be dependent on the MP-inhibitory ability of TIMP-1 in the human breast cancer cell line MDA-MB-435 (Porter et al., Br J Cancer 90: 463, 2004). To shed light on the mechanism by which TIMP-1 stimulates cellular anabolic processes, …
This stimulation has been shown to be dependent on the MP-inhibitory ability of TIMP-1 in the human breast cancer cell line MDA-MB-435 (P
A cystic fibrosis gene editing approach that is on target.
Porter JJ, Lueck JD. Porter JJ, et al. Mol Ther Nucleic Acids. 2024 May 8;35(2):102197. doi: 10.1016/j.omtn.2024.102197. eCollection 2024 Jun 11. Mol Ther Nucleic Acids. 2024. PMID: 38766524 Free PMC article. No abstract available.
Risk factors for acne scarring in Ecuador.
Camacho M, Viteri MI, Yepez P, Porter JE, Belhadi D, Barnes C, Guillemot J. Camacho M, et al. Among authors: porter je. PLoS One. 2024 May 8;19(5):e0285648. doi: 10.1371/journal.pone.0285648. eCollection 2024. PLoS One. 2024. PMID: 38718052 Free PMC article.
Mycobacterium ulcerans challenge strain selection for a Buruli ulcer controlled human infection model.
Muhi S, Buultjens AH, Porter JL, Marshall JL, Doerflinger M, Pidot SJ, O'Brien DP, Johnson PDR, Lavender CJ, Globan M, McCarthy J, Osowicki J, Stinear TP. Muhi S, et al. Among authors: porter jl. PLoS Negl Trop Dis. 2024 May 3;18(5):e0011979. doi: 10.1371/journal.pntd.0011979. eCollection 2024 May. PLoS Negl Trop Dis. 2024. PMID: 38701090 Free PMC article.
3,953 results